Compare FTAI Aviation Ltd (FTAI) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FTAI Aviation Ltd vs Zimmer Biomet Holdings Inc — how do they compare? FTAI Aviation Ltd trades at $169.8 (market cap $17.57B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: FTAI Aviation Ltd and Zimmer Biomet Holdings Inc are close in size by market cap, and FTAI Aviation Ltd pays the higher dividend (1.17%). Which is the better fit depends on your goals — on Pluang, investors hold FTAI Aviation Ltd for 23 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| FTAI | ZBH | |
|---|---|---|
Market Cap | $17.57B | $16.95B |
Volume | 1,905,014 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $310.04 | $103.98 |
52-Week Low | $152.80 | $79.58 |
Typical Hold Time | 23 Days | 89 Days |
Enterprise Value | $20.69B | $24.02B |
Dividend Yield | 1.17% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FTAI Aviation trades at $169.97, down 2.78% with a bearish technical signal despite unanimous analyst buy ratings. The company reported strong 2025 results with $2.51B revenue and $501M net income, though recent quarters missed EPS expectations. Recent developments include a $500M share repurchase program, acquisition of 27 Boeing aircraft, and expanded Asia-Pacific maintenance partnerships, signaling strategic growth initiatives.
FTAI presents a compelling growth story with 100% analyst buy consensus and $321.25 price target representing 89% upside. However, investors face risks from consecutive earnings misses, negative operating cash flow, and declining profit margins. The technical bearish trend and high valuation multiples (P/E 37.35, P/B 43.49) require careful monitoring of execution against growth expectations.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
